NasdaqGS - Nasdaq Real Time Price USD
Arcutis Biotherapeutics, Inc. (ARQT)
13.83
+0.30
+(2.22%)
At close: April 22 at 4:00:01 PM EDT
14.19
+0.36
+(2.60%)
Pre-Market: 8:54:16 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-112,158
-112,158
-247,057
-257,715
-174,627
Investing Cash Flow
28,820
28,820
180,232
-87,199
-75,953
Financing Cash Flow
66,202
66,202
101,323
301,798
281,947
End Cash Position
71,952
71,952
89,323
54,875
97,991
Interest Paid Supplemental Data
22,209
22,209
25,445
12,636
142
Capital Expenditure
-5,143
-5,143
-428
-23,283
-995
Issuance of Capital Stock
161,682
161,682
98,901
176,047
207,490
Issuance of Debt
--
--
--
125,000
73,987
Repayment of Debt
-100,000
-100,000
--
--
--
Free Cash Flow
-117,301
-117,301
-247,485
-280,998
-175,622
12/31/2021 - 1/31/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SWTX SpringWorks Therapeutics, Inc.
40.50
+9.28%
CYTK Cytokinetics, Incorporated
37.81
-0.32%
CCCC C4 Therapeutics, Inc.
1.5600
+11.43%
VRNA Verona Pharma plc
62.01
+3.23%
ADMA ADMA Biologics, Inc.
21.39
+8.91%
ABEO Abeona Therapeutics Inc.
5.28
+7.32%
SPRY ARS Pharmaceuticals, Inc.
15.00
+4.75%
TARS Tarsus Pharmaceuticals, Inc.
49.44
+1.92%
TVTX Travere Therapeutics, Inc.
15.88
+5.10%
ASND Ascendis Pharma A/S
159.13
-1.25%